<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Immunosuppression increases the risk of biliary complications in heart transplant recipients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Patients undergoing heart transplantation since 1986 who were at risk for <z:hpo ids='HP_0001081'>cholelithiasis</z:hpo> (n = 60) were retrospectively studied </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Cholestatic <z:hpo ids='HP_0000952'>jaundice</z:hpo> developed in <z:hpo ids='HP_0000001'>all</z:hpo> patients after the operation because of <z:e sem="disease" ids="C0400979" disease_type="Disease or Syndrome" abbrv="">biliary obstruction</z:e> from <z:hpo ids='HP_0001081'>cholelithiasis</z:hpo>, <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> toxicity, Imuran toxicity, or <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The incidence of <z:hpo ids='HP_0001081'>cholelithiasis</z:hpo> or sludge was 42% (n = 25 of 60) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001081'>Gallstones</z:hpo> developed within 1.8 +/- 1.1 years in 17% of patients (n = 8 of 48) with a <z:mpath ids='MPATH_458'>normal</z:mpath> pretransplantation ultrasonogram </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0151824" disease_type="Disease or Syndrome" abbrv="">Biliary colic</z:e> or <z:mp ids='MP_0002830'>gallstone</z:mp> <z:hpo ids='HP_0001733'>pancreatitis</z:hpo> developed 2 +/- 1.2 years after transplantation in 58% of patients (n = 7 of 12) with asymptomatic <z:hpo ids='HP_0001081'>gallstones</z:hpo> diagnosed before transplantation </plain></SENT>
<SENT sid="6" pm="."><plain>The overall incidence of cholecystectomy or cholecystectomy with Roux-en-Y cystojejunostomy was 40% (n = 24) </plain></SENT>
<SENT sid="7" pm="."><plain>Both open cholecystectomy (n = 5) and laparoscopic cholecystectomy (n = 19) were performed without significant complications </plain></SENT>
<SENT sid="8" pm="."><plain>Recovery is significantly more rapid (p &lt; 0.05) after laparoscopic cholecystectomy versus open cholecystectomy (1 week versus 3 weeks) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This analysis indicates that transplant candidates who have <z:hpo ids='HP_0001081'>gallstones</z:hpo> on pretransplantation evaluation or in whom <z:hpo ids='HP_0001081'>gallstones</z:hpo> develop after transplantation should undergo laparoscopic cholecystectomy at the earliest time in their posttransplantation course (i.e., 3 months) regardless of their symptomatic status </plain></SENT>
<SENT sid="10" pm="."><plain>Removal of the diseased gallbladder not only simplifies the evaluation of cholestatic <z:hpo ids='HP_0000952'>jaundice</z:hpo> by eliminating the need for multiple ultrasonograms to exclude <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001082'>cholecystitis</z:hpo> or <z:e sem="disease" ids="C0701818" disease_type="Disease or Syndrome" abbrv="">choledocholithiasis</z:e> but also safely minimizes the risk of the development of severe biliary complications </plain></SENT>
</text></document>